Shinichiro Machida

454 total citations
39 papers, 258 citations indexed

About

Shinichiro Machida is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Shinichiro Machida has authored 39 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 10 papers in Public Health, Environmental and Occupational Health and 9 papers in Genetics. Recurrent topics in Shinichiro Machida's work include Acute Myeloid Leukemia Research (12 papers), Acute Lymphoblastic Leukemia research (10 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Shinichiro Machida is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Acute Lymphoblastic Leukemia research (10 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Shinichiro Machida collaborates with scholars based in Japan, United States and United Kingdom. Shinichiro Machida's co-authors include Makoto Onizuka, Kiyoshi Ando, Minoru Kojima, Yoshiaki Ogawa, Hiroshi Kawada, Ryujiro Hara, Jun Amaki, Yoko Toda, Yoshiya Tanaka and Junichi Tsukada and has published in prestigious journals such as Blood, Scientific Reports and British Journal of Haematology.

In The Last Decade

Shinichiro Machida

33 papers receiving 254 citations

Peers

Countries citing papers authored by Shinichiro Machida

Since Specialization

Citations

This map shows the geographic impact of Shinichiro Machida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinichiro Machida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinichiro Machida more than expected).

Fields of papers citing papers by Shinichiro Machida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinichiro Machida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinichiro Machida. The network helps show where Shinichiro Machida may publish in the future.

Co-authorship network of co-authors of Shinichiro Machida

This figure shows the co-authorship network connecting the top 25 collaborators of Shinichiro Machida. A scholar is included among the top collaborators of Shinichiro Machida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinichiro Machida. Shinichiro Machida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety of bispecific antibodies in multiple myeloma patients with end-stage renal disease undergoing hemodialysis: a case report of elranatamab and a literature review 2025 ·Annals of Hematology ·(unknown), Rikio Suzuki, (unknown), Yosuke Nakagawa, (unknown), S. Iwata, (unknown), (unknown), Shinichiro Machida, Makoto Onizuka, Yoshiaki Ogawa, Hiroshi Kawada	0
2	ALK-negative anaplastic large cell lymphoma with <i>TP53</i> mutation developing during the administration of baricitinib for atopic dermatitis – A case report – 2025 ·Journal of Clinical and Experimental Hematopathology ·(unknown), S. Iwata, (unknown), Masashi Miyaoka, (unknown), (unknown), Shinichiro Machida, Rikio Suzuki, Makoto Onizuka, Yoshiaki Ogawa, (unknown), Hiroshi Kawada	0
3	Treatment Outcomes of Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed after Allogeneic Stem Cell Transplant in the Era of Novel Immunochemotherapeutic Agents 2024 ·Blood ·Hiroaki Shimizu, Yuho Najima, Shinichi Kako, Takayoshi Tachibana, (unknown), (unknown), Emiko Sakaida, Takuya Miyazaki, Katsuhiro Shono, Kota Yoshifuji, Shinichiro Machida, Takashi Toya, Noriko Doki, Satoru Takada, Kaoru Hatano, Jun Kato, Satoshi Takahashi, Jun Taguchi, Shingo Yano, Yoshinobu Kanda	0
4	Acute myeloid leukemia with a ZMYND11::MBTD1 fusion gene following chemotherapy and radiotherapy for breast cancer: A case report 2024 ·Leukemia Research Reports ·(unknown), (unknown), (unknown), (unknown), Shinichiro Machida, Rikio Suzuki, Makoto Onizuka, Yoshiaki Ogawa, Hiroshi Kawada	0
5	A Nationwide Retrospective Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Hemophagocytic Lymphohistiocytosis 2024 ·Transplantation and Cellular Therapy ·(unknown), (unknown), Kyoko Masuda, Masatoshi Sakurai, Takahide Ara, Kensuke Naito, (unknown), Go Yamamoto, Makoto Osada, Shinichiro Machida, (unknown), Kentaro Fukushima, Yasuo Mori, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Atsuta, Keisuke Kataoka	1
6	Association of CDKN2A/2B deletion with relapse after hematopoietic stem cell transplantation for acute lymphoblastic leukemia 2023 ·PubMed ·Makoto Onizuka, Eri Kikkawa, Shinichiro Machida, (unknown), Rikio Suzuki, (unknown), (unknown), Jun Amaki, Kaito Harada, Ryujiro Hara, (unknown), Yoshiaki Ogawa, Hiroshi Kawada, (unknown)	2
7	Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis 2023 ·Blood Advances ·Takashi Toya, (unknown), Masatoshi Sakurai, Jun Kato, Takehiko Mori, Noriko Doki, (unknown), Nobuyuki Aotsuka, Shokichi Tsukamoto, Emiko Sakaida, Yuki Nakajima, Shin Fujisawa, Shinichiro Machida, (unknown), Hiroki Yokoyama, Katsuhiro Shono, Yoshihiro Hatta, Kensuke Usuki, Keisuke Kataoka, Yoshinobu Kanda	4
8	Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection 2022 ·Journal of Infection and Chemotherapy ·(unknown), Kaito Harada, Makoto Onizuka, (unknown), Ryujiro Hara, (unknown), Jun Amaki, (unknown), Rikio Suzuki, (unknown), Shinichiro Machida, (unknown), Hiroshi Kawada, Yoshiaki Ogawa, Kiyoshi Ando	0
9	Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up 2021 ·Journal of Cancer Survivorship ·Saiko Kurosawa, Takuhiro Yamaguchi, (unknown), (unknown), Takehiko Mori, Masatsugu Tanaka, Tadakazu Kondo, (unknown), Hideki Goto, Satoshi Yoshioka, Shinichiro Machida, Takahiko Sato, Yuta Katayama, Seiko Kato, Katsuhiro Shono, Ishikazu Mizuno, (unknown), Akio Kohno, Miyako Takahashi, Takahiro Fukuda	7
10	An analysis of oral microbial flora by T-RFLP in patients undergoing hematopoietic stem cell transplantation 2020 ·International Journal of Hematology ·Miho Takahashi, (unknown), (unknown), Shinichiro Machida, Eri Kikkawa, Yoshihide Ota, Akihiro Kaneko, Yoshiaki Ogawa, Kiyoshi Ando, Makoto Onizuka	6
11	Primary CNS post-transplant lymphoproliferative disorder following haploidentical HSCT using post-transplant high-dose cyclophosphamide 2019 ·PubMed ·(unknown), Makoto Onizuka, Jun Amaki, (unknown), (unknown), Shinichiro Machida, (unknown), (unknown), (unknown), (unknown), (unknown), Kaito Harada, Yusuke Kondo, Kenichi Hirabayashi, Naoya Nakamura, Yoshiaki Ogawa, Hiroshi Kawada, Kiyoshi Ando	2
12	A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma, Nasal-type and Diffuse Large B-cell Lymphoma 2019 ·Journal of Clinical and Experimental Hematopathology ·(unknown), Hiromichi Matsushita, (unknown), Daisuke Furuya, (unknown), (unknown), Ryujiro Hara, (unknown), (unknown), (unknown), Shinichiro Machida, Makoto Onizuka, Yukari Shirasugi, Yoshiaki Ogawa, Hiroshi Kawada, Naoya Nakamura, Kiyoshi Ando	1
13	Prognostic impact of cytogenetic abnormalities in adult patients with Philadelphia chromosome-negative ALL who underwent an allogeneic transplant 2019 ·Bone Marrow Transplantation ·(unknown), Hiroaki Shimizu, Noriko Doki, Heiwa Kanamori, Toru Sakura, Takehiko Mori, Shinichiro Machida, Satoshi Takahashi, Chikako Ohwada, Shin Fujisawa, Shingo Yano, Maki Hagihara, Yoshinobu Kanda, (unknown), Moritaka Gotoh, Shinichi Kako, Jun Taguchi, Kensuke Usuki, (unknown), Nobuyuki Aotsuka, Shinichiro Okamoto	2
14	Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia 2019 ·International Journal of Hematology ·(unknown), Nahoko Hatsumi, Shuichi Miyawaki, Takahiro Yamauchi, Akihiro Takeshita, Norio Komatsu, Noriko Usui, (unknown), Fumihiro Ishida, Takeshi Morii, Yasuhiko Kano, Michinori Ogura, Shinichiro Machida, Kazuhiro Nishii, Sumihisa Honda, Kazunori Ohnishi, Tomoki Naoe	4
15	NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib 2017 ·International Journal of Hematology ·Ryujiro Hara, Makoto Onizuka, (unknown), Eri Kikkawa, Yoshihiko Nakamura, Hiromichi Matsushita, (unknown), (unknown), Shinichiro Machida, Ken Ohmachi, Yukari Shirasugi, Yoshiaki Ogawa, Hiroshi Kawada, Kiyoshi Ando	21
16	Danaparoid reduces the incidence of hematopoietic stem cell transplantation-associated thrombotic microangiopathy 2016 ·Bone Marrow Transplantation ·Shinichiro Machida, Makoto Onizuka, (unknown), (unknown), (unknown), Jun Amaki, Ryujiro Hara, (unknown), (unknown), Hiroshi Kawada, (unknown)	4
17	Four hepatosplenic T-cell lymphoma cases of Japanese patients 2015 ·Leukemia Research Reports ·(unknown), Hiromichi Matsushita, Ken Ohmachi, Minoru Kojima, Shinichiro Machida, Yoshiaki Ogawa, Hiroshi Kawada, Naoya Nakamura, Kiyoshi Ando	2
18	Single nucleotide polymorphisms of cytarabine metabolic genes influence clinical outcome in acute myeloid leukemia patients receiving high-dose cytarabine therapy 2015 ·International Journal of Hematology ·Jun Amaki, Makoto Onizuka, Ken Ohmachi, (unknown), Ryujiro Hara, (unknown), (unknown), Ai Sato, (unknown), (unknown), Shinichiro Machida, Minoru Kojima, Yukari Shirasugi, Hiroshi Kawada, Yoshiaki Ogawa, Kiyoshi Ando	16
19	Association of autoimmune disease‐related gene polymorphisms with chronic graft‐versus‐host disease 2007 ·British Journal of Haematology ·Masako Shimada, Makoto Onizuka, Shinichiro Machida, Rikio Suzuki, Minoru Kojima, Koichi Miyamura, Yoshihisa Kodera, Hidetoshi Inoko, Kiyoshi Ando	19
20	Imatinib mesylate‐sensitive blast crisis immediately after discontinuation of imatinib mesylate therapy in chronic myelogenous leukemia: Report of two cases 2004 ·American Journal of Hematology ·Takehiro Higashi, Junichi Tsukada, Chiaki Kato, (unknown), (unknown), Shinichiro Machida, Hiroaki Morimoto, Ryosuke Ogawa, Yoko Toda, Yoshiya Tanaka	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact